Patents & IP
NeoPep’s delivery platform is proprietary. TD‑IntelGel™ and Muco‑SmartSeal® are our own patented technologies — which means partners build a differentiated peptide line on IP we control end to end, without depending on a third party’s formulation.
What’s protected
Two proprietary technologies work together to carry a fragile peptide across the buccal membrane and hold it in place.
Our trans-diffusion intelligent gel — a tri-layer hydrogel that stabilises the peptide and drives controlled diffusion through the cheek lining.
An edge-sealing system that maintains prolonged mucosal contact and prevents peptide loss into saliva.
Content pending from NeoPep: exact patent status and scope (filed / granted), jurisdictions/territories covered, application or grant numbers, and priority dates. Share these and we will publish a precise, partner-ready IP position here.
Why it matters to partners
You resell a format competitors can’t simply copy — the differentiation is protected, not generic.
Platform, manufacturing and finished product sit with one owner — no licensing chain to manage or renegotiate.
A clear IP position is one of the first things procurement and BD teams ask for — we make it easy to review.
Licensing and OEM routes let pharma and biotech partners bring their own molecules onto the platform.
We provide a partner IP summary and supporting documentation under NDA on request.